The role of cardiovascular disease risk assessed by ASCVD score in primary thrombosis prophylaxis strategy among antiphospholipid antibody carriers.
作者信息
Zuo Y, Udupa A, Fan J, Makris U E, Karp D R, Shen Y-M
机构信息
1 University of Texas Southwestern Medical Center, Dallas, USA.
2 VA North Texas Health Care System, Dallas, USA.
出版信息
Lupus. 2018 Nov;27(13):2177-2178. doi: 10.1177/0961203318796289. Epub 2018 Aug 31.
Abstract
摘要
相似文献
1
The role of cardiovascular disease risk assessed by ASCVD score in primary thrombosis prophylaxis strategy among antiphospholipid antibody carriers.通过动脉粥样硬化性心血管疾病（ASCVD）评分评估的心血管疾病风险在抗磷脂抗体携带者原发性血栓预防策略中的作用。
Lupus. 2018 Nov;27(13):2177-2178. doi: 10.1177/0961203318796289. Epub 2018 Aug 31.
2
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?原发性抗磷脂抗体阳性个体的血栓预防：2018 年我们处于什么位置？
Curr Rheumatol Rep. 2018 Sep 10;20(11):66. doi: 10.1007/s11926-018-0775-8.
3
Clinical profiles and risk assessment in patients with antiphospholipid antibodies.抗磷脂抗体患者的临床特征与风险评估。
Expert Rev Clin Immunol. 2019 Jan;15(1):73-81. doi: 10.1080/1744666X.2019.1543025. Epub 2018 Nov 13.
4
[Perioperative primary thrombosis prophylaxis for colorectal cancer in an asymptomatic antiphospholipid antibody carrier -a case report and literature review-].[无症状抗磷脂抗体携带者结直肠癌围手术期原发性血栓形成的预防——病例报告及文献综述]
Nihon Shokakibyo Gakkai Zasshi. 2015 Jan;112(1):78-85. doi: 10.11405/nisshoshi.112.78.
5
Management of recurrent thrombosis in antiphospholipid syndrome.抗磷脂综合征中复发性血栓的管理。
Curr Rheumatol Rep. 2014 Mar;16(3):405. doi: 10.1007/s11926-013-0405-4.
6
Thrombosis in the antiphospholipid-antibody syndrome.抗磷脂抗体综合征中的血栓形成。
N Engl J Med. 1995 Sep 7;333(10):665; author reply 666-7.
7
[Suspension of anticoagulation in patients with primary antiphospholipid syndrome in which a negative antibody antiphospholipid].原发性抗磷脂综合征且抗磷脂抗体阴性患者的抗凝治疗中断
Rev Clin Esp. 2009 Jul-Aug;209(7):357-8. doi: 10.1016/s0014-2565(09)71823-5.
8
Diagnosis and Management of the Antiphospholipid Syndrome.抗磷脂综合征的诊断与管理
N Engl J Med. 2018 May 24;378(21):2010-2021. doi: 10.1056/NEJMra1705454.
9
Primary prevention in antiphospholipid antibody carriers.抗磷脂抗体携带者的一级预防。
Lupus. 2012 Jun;21(7):751-4. doi: 10.1177/0961203312445229.
10
Update on antiphospholipid syndrome.抗磷脂综合征的最新进展。
Bull NYU Hosp Jt Dis. 2008;66(3):195-7.
引用本文的文献
1
An Update on Antiphospholipid Syndrome.抗磷脂综合征的最新研究进展。
Curr Rheumatol Rep. 2022 Jan 5;23(12):84. doi: 10.1007/s11926-021-01051-5.
本文引用的文献
1
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.阿司匹林用于心血管疾病和结直肠癌的一级预防：美国预防服务工作组推荐声明。
Ann Intern Med. 2016 Jun 21;164(12):836-45. doi: 10.7326/M16-0577. Epub 2016 Apr 12.
2
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
3
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会心血管风险评估指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959. doi: 10.1016/j.jacc.2013.11.005. Epub 2013 Nov 12.
4
The pathogenesis of the antiphospholipid syndrome.抗磷脂综合征的发病机制。
N Engl J Med. 2013 Mar 14;368(11):1033-44. doi: 10.1056/NEJMra1112830.
5
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?抗磷脂抗体阳性患者的原发性血栓预防：我们处于什么位置？
Curr Rheumatol Rep. 2011 Feb;13(1):59-69. doi: 10.1007/s11926-010-0149-3.
Zotero 插件